Ginkgo Bioworks Holdings, Inc.(NYSE:DNA) 
Ginkgo Bioworks Holdings, Inc. develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty ch...
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 5.48
H 5.59
L 5.00
C 5.57
V 1,859,323
10EMA 5.57
20EMA 5.57
60EMA 5.57
120EMA 5.57
250EMA 5.57